C-squared Pharma Ltd, based in Ireland, is a pharmaceutical company.
One of their notable products is LATANOPROST USP, with a corresponding US DMF Number 23539.
Remarkably, this DMF maintains an Active status since its submission on February 13, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 09, 2013, and payment made on December 05, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II